Xelpac Premium Paclitaxel Sorafenib Tosylate
MajorSorafenib should not be given together with carboplatin and paclitaxel if the patient has squamous cell lung cancer. In studies of patients with this type of lung cancer, more of them died when sorafenib was added to carboplatin and paclitaxel than when they had carboplatin and paclitaxel alone. Doctors therefore treat this combination as off limits (contraindicated) for squamous cell lung cancer.
These medicines can affect each other in a serious way. Do not start taking them together unless your doctor has said it is OK. If you already take both, do not stop either one on your own: speak to your doctor or pharmacist soon.